Aeterna Zentaris
AEZS
#10173
Rank
NZ$29.29 M
Marketcap
NZ$9.57
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): NZ-$3.38

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is NZ-$3.43. In 2022 the company made an earnings per share (EPS) of NZ-$7.83 a decrease over its 2021 EPS that were of NZ-$3.04.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$3.38
2022NZ-$7.83157.14%
2021NZ-$3.04-41.48%
2020NZ-$5.20-64.46%
2019NZ-$14.64-240%
2018NZ$10.45-122.32%
2017NZ-$46.83-53.53%
2016NZ-$100.77-86.71%
2015NZ-$758.52-35.21%
2014NZ-$1,171-216.67%
2013NZ$1,004-123.3%
2012NZ-$4,307-40.8%
2011NZ-$7,276-6.45%
2010NZ-$7,778-27.91%
2009NZ-$10,788-61.61%
2008NZ-$28,10083.61%
2007NZ-$15,304-195.31%
2006NZ$16,057178.26%
2005NZ$5,770-330%
2004NZ-$2,509-80.05%
2003NZ-$12,57617.78%
2002NZ-$10,677515.93%
2001NZ-$1,734-68.6%
2000NZ-$5,521119.62%
1999NZ-$2,514-3.63%
1998NZ-$2,609

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.31-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$3.45-200.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$4.97-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.60-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$8.18-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA